about
In vivo screening of hepatocellular carcinoma using AC susceptibility of anti-alpha fetoprotein-activated magnetic nanoparticles.A noninvasive method to determine the fate of Fe(3)O(4) nanoparticles following intravenous injection using scanning SQUID biosusceptometry.Using bio-functionalized magnetic nanoparticles and dynamic nuclear magnetic resonance to characterize the time-dependent spin-spin relaxation time for sensitive bio-detectionDual-imaging model of SQUID biosusceptometry for locating tumors targeted using magnetic nanoparticles.Magnetic Clustering Effect during the Association of Biofunctionalized Magnetic Nanoparticles with Biomarkers.Assaying Carcinoembryonic Antigens by Normalized Saturation Magnetization.Rapid and quantitative discrimination of tumour cells on tissue slices.Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles.Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe3O4 magnetic nanoparticles.The magnetic-nanofluid heat pipe with superior thermal properties through magnetic enhancement.Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivoCombined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease.Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer's Disease.Plasma α-synuclein predicts cognitive decline in Parkinson's disease.Ultrasound-Induced Magnetic Imaging of Tumors Targeted by Biofunctional Magnetic Nanoparticles.Immunomagnetic Reduction Assay on Des-Gamma-Carboxy Prothrombin for Screening of Hepatocellular Carcinoma.Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical ApplicationsPlasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.Ultra-highly sensitive and wash-free bio-detection of H5N1 virus by immunomagnetic reduction assays.Wash-free, antibody-assisted magnetoreduction assays of orchid viruses.In vivo and real-time measurement of magnetic nanoparticles distribution in animals by scanning SQUID biosusceptometry for biomedicine study.Designing optical-fiber modulators by using magnetic fluids.Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay.Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.Simultaneous identification of the low-field-induced tiny variation of complex refractive index for anisotropic and opaque magnetic-fluid thin film by a stable heterodyne Mach-Zehnder interferometerExploration of the relationship between the tumor burden and the concentration of vascular endothelial growth factor in liver-cancer-bearing animals using immunomagnetic reduction assayMagnetically enhanced high-specificity virus detection using bio-activated magnetic nanoparticles with antibodies as labeling markersExperimental study on low-detection limit for immunomagnetic reduction assays by manipulating reagent entitiesComposite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome
P50
Q34442056-5CD49AF7-D7CE-4678-BD9D-8CD590BFC958Q34477355-751502D4-649B-4CD4-A8CE-4D7B4C35C4A0Q34786947-42CA351C-66C8-44C6-86EB-5C1D2662F6CCQ35085610-E29CEC4C-0F69-43D6-BBF5-8648C93DEB1EQ35745165-F878582A-424F-4E0C-8FE0-1A7FEED29151Q35848988-30351A52-55E4-417B-B1BE-E9C97B646CAAQ36006576-453F7330-68BA-49F1-B6A1-7D5C92D0A0ECQ36015518-45B71A24-372F-4E67-BD06-76F54599ACA2Q36058816-A6CB787E-AEBA-4870-887E-444DD8C85B37Q36083221-CD3624B7-28BC-4833-8CA8-B4A2498FD947Q36281506-F3138636-9610-4FB6-A78F-2E8697CC16CBQ36982173-F852A349-7285-4B39-AB81-A85380811284Q37366302-FB646EB6-D37D-436F-A978-6B5C9D8E3C8CQ37403102-B5160D63-94D4-4566-94C5-1153C3953DD4Q37588576-D9CE44E4-9857-45E2-A8F5-BA80543149E1Q38760749-8B7EDCCB-F49D-49BD-A548-A8752937463FQ38918770-20C4F5BF-2C0E-4F43-BEB9-F3AB164F01BBQ38959071-0ADEAF68-23B2-44B1-86E8-E4CF6CEE6337Q42253614-901C5DA9-975E-4AC4-87C8-C7AB177B3FC3Q43863392-EF068EA3-D637-46F4-BCD5-66E5C1E9A4B9Q45391740-D16EDCB4-AA3F-47A9-9723-D9D06C4AB685Q47817532-F7CADCAB-2102-4D13-B137-42CBBED2B31BQ50693100-3E915A85-B0E0-4B32-9D40-DD4F7F9476C8Q51522072-5E77B4A6-268F-425C-ABE3-5ABAECD3C30AQ51732196-516BE195-7F1E-41B1-A541-37F2DD62DCEFQ55110559-3F6C8EBF-5E8E-4224-905B-0DEC9DF9C50DQ84706319-3C7376F6-AE46-4DA6-ADB7-4BE5BA71004FQ84835380-EC1AD8B4-F230-4DBD-8FA4-270FF5909360Q84960622-3B7ADEF5-2DB9-40D8-8247-B0861FBB2503Q86081195-74CE111A-3EF9-4E5E-A194-94CC10B7044BQ91680162-6BBE20ED-99DB-4A1E-A591-F84DF50ED84A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7144-2637
@en
name
Jen-Jie Chieh
@ast
Jen-Jie Chieh
@en
Jen-Jie Chieh
@es
Jen-Jie Chieh
@nl
type
label
Jen-Jie Chieh
@ast
Jen-Jie Chieh
@en
Jen-Jie Chieh
@es
Jen-Jie Chieh
@nl
prefLabel
Jen-Jie Chieh
@ast
Jen-Jie Chieh
@en
Jen-Jie Chieh
@es
Jen-Jie Chieh
@nl
P106
P1153
6507544348
P2456
P31
P496
0000-0002-7144-2637